Evidence map›Paper›PMID 37599864›Full record

ArticleFrontiers in pain research (Lausanne, Switzerland)2023

AAV-mediated gene transfer to colon-innervating primary afferent neurons.

Reshma Gore, Tina Esmail, Kelsey Pflepsen, Ezequiel Marron Fernandez de Velasco, Kelley F Kitto, Maureen S Riedl, Andrea Karlen, R Scott McIvor, Christopher N Honda, Carolyn A Fairbanks and 1 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pain research (Lausanne, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Reshma GoreDepartment of Neuroscience, University of Minnesota, Minneapolis, MN, United States.
Tina EsmailDepartment of Neuroscience, University of Minnesota, Minneapolis, MN, United States.
Kelsey PflepsenDepartment of Pharmaceutics, University of Minnesota, Minneapolis, MN, United States.
Ezequiel Marron Fernandez de VelascoDepartment of Pharmacology, University of Minnesota, Minneapolis, MN, United States.
Kelley F KittoDepartment of Neuroscience, University of Minnesota, Minneapolis, MN, United States.
Maureen S RiedlDepartment of Neuroscience, University of Minnesota, Minneapolis, MN, United States.
Andrea KarlenDepartment of Genetics, Cell Biology and Development, University of Minnesota, Minneapolis, MN, United States.
R Scott McIvorDepartment of Genetics, Cell Biology and Development, University of Minnesota, Minneapolis, MN, United States.
Christopher N HondaDepartment of Neuroscience, University of Minnesota, Minneapolis, MN, United States.
Carolyn A FairbanksDepartment of Neuroscience, University of Minnesota, Minneapolis, MN, United States.
Lucy VulchanovaDepartment of Neuroscience, University of Minnesota, Minneapolis, MN, United States.
University of Minnesota · US

Funding

Selective peripheral neuromodulation through organ-specific AAV-mediated gene transferU18EB021716 · NIBIB · UNIVERSITY OF MINNESOTA · PI VULCHANOVA, LYUDMILA H · 2015 to 2016
$456k
NIBIB NIH HHS U18 EB021716
6 · The paper itself

Abstract

Investigation of neural circuits underlying visceral pain is hampered by the difficulty in achieving selective manipulations of individual circuit components. In this study, we adapted a dual AAV approach, used for projection-specific transgene expression in the CNS, to explore the potential for targeted delivery of transgenes to primary afferent neurons innervating visceral organs. Focusing on the extrinsic sensory innervation of the mouse colon, we first characterized the extent of dual transduction following intrathecal delivery of one AAV9 vector and intracolonic delivery of a second AAV9 vector. We found that if the two AAV9 vectors were delivered one week apart, dorsal root ganglion (DRG) neuron transduction by the second vector was greatly diminished. Following delivery of the two viruses on the same day, we observed colocalization of the transgenes in DRG neurons, indicating dual transduction. Next, we delivered intrathecally an AAV9 vector encoding the inhibitory chemogenetic actuator hM4D(Gi) in a Cre-recombinase dependent manner, and on the same day injected an AAV9 vector carrying Cre-recombinase in the colon. DRG expression of hM4D(Gi) was demonstrated at the mRNA and protein level. However, we were unable to demonstrate selective inhibition of visceral nociception following hM4D(Gi) activation. Taken together, these results establish a foundation for development of strategies for targeted transduction of primary afferent neurons for neuromodulation of peripheral neural circuits.

Indexed as

AAVchemogeneticcolonintrathecalnociceptionsensoryvisceral

Identifiers

PMID37599864
PMCPMC10436501
OpenAlexW4385583718

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.